VC  Otter Capital

http://www.ottercapital.com





     Office Locations:

755 Page Mill Road, Suite A200
Palo Alto, CA 94304
Phone: 650-493-5263

 

Stages:

  • Early


 

Industries:

  • Information Technology

  •  

    Description:

    Otter Capital makes equity investments in companies that have good growth prospects, substantial competitive advantages and barriers to entry, and the current or future ability to generate significant cash returns on the capital deployed in the business. Otter Capital was founded by John Pasquesi, formerly a Managing Director and member of the Executive Committee of Hellman & Friedman, LLC, a private equity investment firm.



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)
    $2M-$7M
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     

    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription or Silicon Valley Database subscription.
    John Pasquesi Founder

     

    Recent Funding Events (trailing 12 months):


      Date


      Name


      State


      Amount


      Stage


      09/07/2017


      NewLeaf Symbiotics


      MO


      $30,000,000


      Series C


      07/10/2017


      NewLeaf Symbiotics


      MO


      $24,000,000


      Series C


     

    Portfolio companies include:


      Agraquest
        web link


      Arch Capital Group
        web link


      Arena Solutions
        web link


      BioConsortia
        web link


      Decimal
        web link


      Equity Risk Partners
        web link


      GLMX
        web link


      Green & Grow
        web link


      Inguran
        web link


      NewLeaf Symbiotics
        web link


      Norl
        web link


      Overstock.com
        web link


      WSA Global Holdings
        web link


     

    Recent News: